Since IL-22 has been shown to promote tissue pathology during toxoplasmosis [38–40], it was unexpected that Ahr-/- mice with a marked defect in IL-22-producing RORγt+ ILCs would develop increased intestinal pathology. This evidence concerns the gene IL22 and toxoplasmosis.